The DOI matches its Crossref record; 343 of the 343 references it cites were found in a registry or an index.
Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Ram, F. S., Rodriguez-Roisin, R., Granados-Navarrete, A., Garcia-Aymerich, J., & Barnes, N. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004403.pub2 · Cited by 170
RetractedReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Research works printed but not linked: 9
- WHO meeting participants, 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- The Tobacco Use and Dependence Clinical Practice Guideline Panel, 2000, A clinical practice guideline for treating tobacco use and dependence, JAMA, 28, 3244
- Vogiatzis, 2016, American Thoracic Society/European Respiratory Society Task Force on Policy in Pulmonary Rehabilitation, Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J, 47, 1336
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Vogelmeier, 2011, Tiotropium versus salmeterol for the prevention of exacerbations of COPD, N Engl J Med, 364, 1093, 10.1056/NEJMoa1008378 · DOI · Paper page
- Hurst, 2010, Susceptibility to exacerbation in chronic obstructive pulmonary disease, N Engl J Med, 363, 1128, 10.1056/NEJMoa0909883 · DOI · Paper page
- Vestbo, 2016, Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial, Lancet, 387, 1817, 10.1016/S0140-6736(16)30069-1 · DOI · Paper page
- Houben-Wilke, 2016, Peripheral Artery Disease and its Clinical Relevance in Patients with COPD in the COSYCONET Study, Am J Respir Crit Care Med
- Jaramillo, 2015, Erratum: reduced bone density and vertebral fractures in smokers. men and COPD patients at increased risk, Ann Am Thorac Soc, 12, 1112, 10.1513/AnnalsATS.201412-591OC · DOI
Cited by
Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung
Genschmer, K. R., Russell, D. W., Lal, C., Szul, T., Bratcher, P. E., Noerager, B. D., Abdul Roda, M., Xu, X., Rezonzew, G., Viera, L., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.002 · Cited by 445
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection
Huang, D. T., Yealy, D. M., Filbin, M. R., Brown, A. M., Chang, C.-C. H., Doi, Y., Donnino, M. W., Fine, J., Fine, M. J., Fischer, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802670 · Cited by 434
Progress in the mechanism and targeted drug therapy for COPD
Wang, C., Zhou, J., Wang, J., Li, S., Fukunaga, A., Yodoi, J., & Tian, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00345-x · Cited by 303
Bellou, V., Belbasis, L., Konstantinidis, A. K., Tzoulaki, I., & Evangelou, E. (2019) · BMJ · doi:10.1136/bmj.l5358 · Cited by 197
Criner, G. J., Delage, A., Voelker, K., Hogarth, D. K., Majid, A., Zgoda, M., Lazarus, D. R., Casal, R., Benzaquen, S. B., Holladay, R. C., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0383oc · Cited by 182
Self-citation
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodríguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Venue
- Archivos de Bronconeumología
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 53
- Issue
- 3
- Pages
- 128-149
- ISSN
- 0300-2896 (ISSN-L)
- OpenAlex
- W2592919648
- Cited by
- 309
- References
- 343
- FWCI
- 41.11
- Type
- journal article
- Language
- es
- Update notices
- erratum (2017-07-01)
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD. https://app.cochat.ai/papers/10.1016/j.arbres.2017.02.001
- The paper
- Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodríguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., . . . Agustí, A. (2017). Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD. Archivos de Bronconeumología. https://doi.org/10.1016/j.arbres.2017.02.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
